Douglas W. Hanto, M.D., Ph.D.
Professor of Surgery and Associate Director for Vanderbilt Transplant Center, Vanderbilt University, Tennessee
Lewis Thomas Professor of Surgery Emeritus, Harvard Medical School
Dr. Douglas W. Hanto is Professor of Surgery and Associate Director of the Vanderbilt Transplant Center, Vanderbilt University, Tennessee. He is one of the most distinguished leaders in the transplant community and is also the Lewis Thomas Professor of Surgery Emeritus at Harvard University.
Dr. Hanto received his M.D. from the University of Arizona College of Medicine, and his Ph.D. in Surgery from the University of Minnesota. He completed his surgical training, research fellowship, and transplant fellowship at the University of Minnesota in Minneapolis. Dr. Hanto is an active clinical transplant and hepatobiliary surgeon and has been involved in patient care and the training and mentoring of surgery residents and transplant fellows for more than 25 years. He has many original research contributions including the description of the clinical syndromes associated with post-transplant lymphoproliferative diseases (PTLD), their association with the Epstein-Barr virus (EBV), the morphological features that correlated with clinical presentation, and demonstrated that they were polyclonal B-cell proliferations that could evolve into monoclonal B-cell proliferations—resulting in improved techniques for preventing and treating these diseases. Dr. Hanto’s laboratory research is currently focused on the ability of carbon monoxide (CO) at low concentrations to be protective in animal models of ischemia-reperfusion injury and delayed graft function and in hepatic regeneration. Dr. Hanto also has an interest in and has written on topics in transplant ethics (solicitation, organ allocation) and health care disparities, and along with Dr. Keren Ladin, has investigated and written about the role of social networks and other factors in these disparities.
Dr. Hanto is an Associate Editor of the American Journal of Transplantation. He is a director of the American Board of Surgery and has served as Chair of the Ethics Committee of both the Transplantation Society (International) and the American Society of Transplantation. He has held many other leadership positions in the field of transplantation. He has published over 220 articles, book chapters, editorials, and reviews.